Epidemiology and economic burden of Huntington’s disease: a Canadian provincial public health system perspective

References

• Bates GP, Dorsey R, Gusella JF, et al. Huntington disease. Nat Rev Dis Primers. 2015;1:15005.
   PubMed Web of Science ®Google Scholar
• Langbehn DR, Brinkman RR, Falush D, et al. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet. 2004;65(4):267–277.
   PubMed Web of Science ®Google Scholar
• Fisher ER, Hayden MR. Multisource ascertainment of Huntington disease in Canada: prevalence and population at risk. Mov Disord. 2014;29(1):105–114.
   PubMed Web of Science ®Google Scholar
• Gaskin J, Gomes J, Darshan S, et al. Burden of neurological conditions in Canada. Neurotoxicology. 2017;61:2–10.
   PubMed Web of Science ®Google Scholar
• Rawlins MD, Wexler NS, Wexler AR, et al. The prevalence of Huntington's disease. Neuroepidemiology. 2016;46(2):144–153.
   PubMed Web of Science ®Google Scholar
• Kay C, Collins JA, Wright GEB, et al. The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population. Am J Med Genet B Neuropsychiatr Genet. 2018;177(3):346–357.
   PubMed Web of Science ®Google Scholar
• Fisher F, Andrews S, Churchyard A, et al. Home or residential care? The role of behavioral and psychosocial factors in determining discharge outcomes for inpatients with Huntington's disease. J Huntingtons Dis. 2012;1(2):187–193.
   PubMedGoogle Scholar
• Divino V, Dekoven M, Warner JH, et al. The direct medical costs of Huntington's disease by stage. A retrospective commercial and Medicaid claims data analysis. J Med Econ. 2013;16(8):1043–1050.
   PubMedGoogle Scholar
• Clark D. Percentage change year-on-year of the consumer price index (CPI) in the United Kingdom (UK) from 2000 to 2018; 2019. Available from: https://www.statista.com/statistics/306648/inflation-rate-consumer-price-index-cpi-united-kingdom-uk/
   Google Scholar
• Organisation for Economic Co-operation and Development. Exchange rates (indicator); 2019. Available from: https://data.oecd.org/conversion/exchange-rates.htm
   Google Scholar
• Jones C, Busse M, Quinn L, et al. The societal cost of Huntington's disease: are we underestimating the burden? Eur J Neurol. 2016;23(10):1588–1590.
   PubMed Web of Science ®Google Scholar
• Yomtoob J, Yeh C, Bega D. Ancillary service utilization and impact in Huntington's disease. J Huntingtons Dis. 2019;8(3):301–310.
   PubMed Web of Science ®Google Scholar
• Ohlmeier C, Saum KU, Galetzka W, et al. Epidemiology and health care utilization of patients suffering from Huntington's disease in Germany: real world evidence based on German claims data. BMC Neurol. 2019;19(1):318.
   PubMed Web of Science ®Google Scholar
• Silva-Paredes G, Urbanos-Garrido RM, Inca-Martinez M, et al. Economic burden of Huntington's disease in Peru. BMC Health Serv Res. 2019;19(1):1017.
   PubMed Web of Science ®Google Scholar
• Wexler NS, Collett L, Wexler AR, et al. Incidence of adult Huntington's disease in the UK: a UK-based primary care study and a systematic review. BMJ Open. 2016;6(2):e009070.
   PubMed Web of Science ®Google Scholar
• Carrassi E, Pugliatti M, Govoni V, et al. Epidemiological study of Huntington's disease in the province of Ferrara, Italy. Neuroepidemiology. 2017;49(1–2):18–23.
   PubMed Web of Science ®Google Scholar
• Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–682.
   PubMed Web of Science ®Google Scholar
• Statistics Canada. Table 18-10-0005-01 Consumer Price Index, annual average, not seasonally adjusted. Available from: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1810000501
   Google Scholar
• Kodra Y, Minelli G, Rocchetti A, et al. The Italian National Rare Diseases Registry: a model of comparison and integration with hospital discharge data. J Public Health (Oxf). 2019;41(1):46–54.
   PubMed Web of Science ®Google Scholar
• Vicente E, Ruiz de Sabando A, Garcia F, et al. Validation of diagnostic codes and epidemiologic trends of Huntington disease: a population-based study in Navarre, Spain. Orphanet J Rare Dis. 2021;16(1):77.
   PubMed Web of Science ®Google Scholar
• Bruzelius E, Scarpa J, Zhao Y, et al. Huntington's disease in the United States: variation by demographic and socioeconomic factors. Mov Disord. 2019;34(6):858–865.
   PubMed Web of Science ®Google Scholar
• Almqvist EW, Elterman DS, MacLeod PM, et al. High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia. Clin Genet. 2001;60(3):198–205.
   PubMed Web of Science ®Google Scholar
• Squitieri F, Griguoli A, Capelli G, et al. Epidemiology of Huntington disease: first post-HTT gene analysis of prevalence in Italy. Clin Genet. 2016;89(3):367–370.
   PubMed Web of Science ®Google Scholar
• Evans SJ, Douglas I, Rawlins MD, et al. Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records. J Neurol Neurosurg Psychiatry. 2013;84(10):1156–1160.
   PubMed Web of Science ®Google Scholar
• Baig SS, Strong M, Quarrell OW. The global prevalence of Huntington's disease: a systematic review and discussion. Neurodegener Dis Manag. 2016;6(4):331–343.
   PubMed Web of Science ®Google Scholar
• Organisation for Economic Co-operation and Development. Doctors' consultations (indicator); 2021. Available from: https://data.oecd.org/healthcare/doctors-consultations.htm
   Google Scholar
• Canadian Institute for Health Information. The burden of neurological diseases, disorders and injuries in Canada. Ottawa: CIHI; 2007.
   Google Scholar
• Institute of Health Economics. IHE in your pocket: a handbook of health economic statistics 2017. Edmonton: IHE; 2017. Available from: https://www.ihe.ca/download/ihe_in_your_pocket_2017.pdf
   Google Scholar
• Canadian Institute for Health Information. Ottawa: CIHI; 2021. Available from: https://www.cihi.ca/en/national-health-expenditure-trends
   Google Scholar
• Public Health Agency of Canada. Mapping connections: an understanding of neurological conditions in Canada. Ottawa: Government of Canada; 2014.
   Google Scholar
• Dorey J, De Nicola N, Tedroff J, et al. PND38: International comparison of Huntington disease (HD) burden. Value Health. 2011;14(7):A324.
   Web of Science ®Google Scholar
• Dorey J, Toumi M, Clay E, et al. [PND12] European-Huntington’s disease burden study (EURO-HDB): preliminary results for Italy and France. Value Health. 2010;13(7):A389–A390.
   Google Scholar
• 2 – Disease burden of Huntington’s disease in a Canadian setting using administrative health data. Abstracts of the 28th Annual Meeting of the Huntington Study Group, November 4–6, 2021. J Huntingtons Dis. 2021;10(s1):S1–S41.
   PubMed Web of Science ®Google Scholar